Stock Evaluator: USANA Health Sciences, Inc. (USNA)

USANA Health Sciences, Inc. USNA

$13.57 0.03 0.22%
November 17, 2026 4:00:03 PM EST November 10, 2021 Volume: 159,576
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NYSE | DELAYED PRICE
SECTOR INDUSTRY
Consumer Staples Personal Care Products

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. It operates in two segments, Core nutritional and Hiya Direct-To-Consumer. The company offers USANA nutritional optimizers, including supplements for cardiovascular health, skeletal/structural health, and digestive health; Essentials/CellSentials, such as vitamin and mineral supplements for age group beginning with children 13 months of age; and food products that include meal replacement shakes, snack bars, and other related products for healthy weight management, digestive health, and energy and hydration. It offers Celavive, a skincare regimen for various skin care types and ethnicities; and all other products comprising materials and online tools for associates to build business and marketing of products The company sells its products through retail customers, a subscription model, and direct selling, as well as online. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.

Commentary & Analysis


Financial Summary

Share Statistics USNA Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $250.9 $250.9 31%
Shares Out (Mil) 18.5 22.7 29%
Institutional Ownership 55.3% 62.9% 37%
Float (Mil) 8.9 31.5 18%
Beta 0.67 0.70 38%
Avg Daily Volume (000s) 224 140 46%
Price Change
(52-week)
(29.3%) 52.8% 31%
Growth USNA Industry
Median
Percentile
(All Stocks)
Sales (5yr) (4.0%) (0.9%) 10%
Net Income (5yr) (38.7%) (8.8%) 10%
EPS (5yr) (37.0%) (1.3%) 6
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (18.5%) (15.9%) 37%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 1 1 1
Current EPS $0.120 $0.550 $1.250
Month Ago EPS $0.110 $0.760 $1.770
# Rev Up 0 0 1
# Rev Down 1 1 0
Three Months Ago EPS $0.110 $0.760 $1.770
Year/Year Chg (140.0%) (5.2%) 189.7%
Financials USNA Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $906 $650 49%
Net Income (TTM) (Mil) ($21) $3 23%
EPS (TTM) ($1.151) $0.200 19%
Operating Cash Flow (TTM) (Mil) $42 $20 45%
Net Cash Flow (TTM) (Mil) $34 $3 67%
Long-Term Debt (Q1) (Mil) $0 $28 0%
Enterprise Value (Q1) (Mil) $115 $268 23%
Valuation USNA Industry
Median
Percentile
(All Stocks)
P/B 0.48 1.23 11%
P/E na 14.5 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 0.4 na
Ratios USNA Industry
Median
Percentile
(All Stocks)
Gross Margin 77.3% 63.3% 87%
Net Margin (2.3%) 3.3% 27%
ROA (3.0%) 1.9% 32%
ROE (4.0%) (3.2%) 31%
Liabilities to Assets 19.5% 47.3% 12%
F-Score 3 5 18%

USANA Health Sciences, Inc. did not pass any screens on 11/17/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors